Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors

doi:10.3748/wjg.v16.i24.2963

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 24

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6909)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

544

HTML

5828

Figures (1-3)

305

Tables (1-3)

232

Sum=6909

Jun 28, 2010 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (92)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Jun 28, 2010; 16(24): 2963-2970
Published online Jun 28, 2010. doi: 10.3748/wjg.v16.i24.2963

Full Size Figure Download Figure

Figure 3 Kaplan Meier curve demonstrating time to tumor progression in patients treated with octreotide long-acting repeatable (LAR) vs placebo[69]. Log-rank test stratified by functional activity: P = 0.000072, HR = 0.34 (95% CI: 0.20-0.59).

Citation: Strosberg J, Kvols L. Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors. World J Gastroenterol 2010; 16(24): 2963-2970
URL: https://www.wjgnet.com/1007-9327/full/v16/i24/2963.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i24.2963